Six-coordinate distorted octahedral tetracyanidonitridorhenium(V) and -technetium(V) complexes with a volatile organic compound (VOC) coordinating at the trans position of a nitrido ligand, (PPh4)2[MN(CN)4L] (M = Re, L = MeOH, EtOH, acetone, or MeCN; M = Tc, L = MeOH), and five-coordinate square-pyramidal tetracyanidonitrido complexes without an axial ligand, (PPh4)2[MN(CN)4] (M = Re or Tc), were synthesized and characterized. Single-crystal X-ray structural analysis was carried out for (PPh4)2[MN(CN)4L] (M = Re, L = MeOH, EtOH, or acetone; M = Tc, L = MeOH) and (PPh4)2[ReN(CN)4]. All complexes studied showed photoluminescence in the solid state at room temperature. Reversible luminescence switching between six- and five-coordinate rhenium(V) complexes and between the relevant six-coordinate rhenium(V) complexes except that between the MeCN and acetone complexes was achieved by exposing them to VOC vapor in the solid state at room temperature. Luminescence changes were observed from the five-coordinate technetium(V) complexes in a MeOH vapor atmosphere in the solid state. In contrast, no vapochromic luminescence was observed from the five- and six-coordinate complexes in an acetone vapor atmosphere.

BackgroundBoron neutron capture therapy (BNCT) is a molecular radiation treatment based on the 10B (n, α) 7Li nuclear reaction in cancer cells, in which delivery of 10B by 4-borono-phenylalanine conjugated with fructose (BPA-fr) to the cancer cells is of critical importance. The PET tracer 4-borono-2-18 F-fluoro-phenylalanine (FBPA) has been used to predict the accumulation of BPA-fr before BNCT. However, because of the difference in chemical structure between BPA-fr and FBPA and the difference in the dose administered between BPA-fr (therapeutic dose) and FBPA (tracer dose), the predictive value of FBPA PET for BPA-fr accumulation in the tumor and normal tissues is not yet clearly proven. We conducted this study to validate FBPA PET as a useful test to predict the accumulation of BPA-fr in the tumor and normal tissues before BNCT.MethodsRGC-6 rat glioma cells (1.9 × 107) were implanted subcutaneously in seven male F344 rats. On day 20 after the tumor implantation, dynamic PET scan was performed on four rats after injection of FBPA for 1 h. Whole-body PET/CT was performed 1 h after intravenous injection of the FBPA solution (30.5 ± 0.7 MBq, 1.69 ± 1.21 mg/kg). PET accumulation of FBPA in the tumor tissue and various normal tissues was estimated as a percentage of the injected dose per gram (%ID/g). One hour after the PET/CT scan, BPA-fructose (167.32 ± 18.65 mg/kg) was injected intravenously, and the rats were dissected 1 h after the BPA-fr injection. The absolute concentration of 10B in the autopsied tissues and blood was measured by inductively coupled plasma optical emission spectrometry (ICP-OES).ResultsThe highest absolute concentration of 10B determined by ICP-OES was found in the kidney (4.34 ± 0.84 %ID/g), followed by the pancreas (2.73 ± 0.63 %ID/g), and the tumor (1.44 ± 0.44 %ID/g). A significant positive correlation was found between the accumulation levels of BPA-fr and FBPA (r = 0.91, p < 0.05).ConclusionsFBPA PET can reliably predict accumulation of BPA-fr in the tumor as well as normal tissues.

This study shows the utility of F-FBPA as a tumor-specific probe of LAT1 with low accumulation in the inflammatory lesions.

Cell-sheet transplantation induces angiogenesis for chronic myocardial infarction (MI), though insufficient capillary maturation and paucity of arteriogenesis may limit its therapeutic effects. Omentum has been used clinically to promote revascularization and healing of ischemic tissues. We hypothesized that cell-sheet transplantation covered with an omentum-flap would effectively establish mature blood vessels and improve coronary microcirculation physiology, enhancing the therapeutic effects of cell-sheet therapy. Rats were divided into four groups after coronary ligation; skeletal myoblast cell-sheet plus omentum-flap (combined), cell-sheet only, omentum-flap only, and sham operation. At 4 weeks after the treatment, the combined group showed attenuated cardiac hypertrophy and fibrosis, and a greater amount of functionally (CD31(+)/lectin(+)) and structurally (CD31(+)/α-SMA(+)) mature blood vessels, along with myocardial upregulation of relevant genes. Synchrotron-based microangiography revealed that the combined procedure increased vascularization in resistance arterial vessels with better dilatory responses to endothelium-dependent agents. Serial (13)N-ammonia PET showed better global coronary flow reserve in the combined group, mainly attributed to improvement in the basal left ventricle. Consequently, the combined group had sustained improvements in cardiac function parameters and better functional capacity. Cell-sheet transplantation with an omentum-flap better promoted arteriogenesis and improved coronary microcirculation physiology in ischemic myocardium, leading to potent functional recovery in the failing heart.

No abstract